ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

NCI, Litton Open Talks On Frederick Contract

February 6, 1976

More DCT Concepts Approved By Advisors

July 10, 1992

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Iniparib Plus Chemo Shows Benefit In Phase II Study

January 28, 2011

NIH Carcinogen Guidelines Offered

April 24, 1981

In Brief: BRCA 2 Gene sequence Published; CALGB To Mark 40th Anniversary

March 8, 1996